kentucky glp-1 constipation lawsuit Trulicity [2026] Intel | Lawsuit Alleges Medspa

A more mindful, wellness-forward approach to GLP-1 use

A critical analysis of recent literature highlights the importance of integrative and cautious approaches that account for the developmental plasticity of the pediatric organism and the possible pleiotropic effects of early pharmacological intervention.

Labs were unremarkable upon admission

Glucagon-like peptide-1 receptor (GLP-1R) is a versatile therapeutic target that regulates glucose homeostasis, cardiovascular function, neuroprotection, and immune responses

We present the case of a 14-year-old female patient with autism, developmental delay, and obesity managed with semaglutide who presented for esophagogastroduodenoscopy and colonoscopy

Chen Gilor is leading a large pilot study of a GLP-1 weight loss drug called MEOW-1, or ManagEment of Over Weight cats.